Skip to main content
35°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NLS Pharmaceutics Ltd. - Common Shares
(NQ:
NLSP
)
2.260
-0.040 (-1.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NLS Pharmaceutics Ltd. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
February 11, 2025
Via
Benzinga
The market is filled with gapping stocks in Monday's session.
February 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Monday's pre-market session: top gainers and losers
February 10, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
What's Going On With NLS Pharmaceutics Shares Monday?
November 04, 2024
NLS Pharmaceutics shares are moving higher on Monday after the company announced it entered into a definitive merger agreement with Kadimastem.
Via
Benzinga
NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
July 29, 2024
Via
ACCESSWIRE
Which stocks are most active on Friday?
January 31, 2025
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via
Chartmill
Dow Edges Lower; Exxon Mobil Earnings Top Views
January 31, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With NLS Pharmaceutics Stock Friday?
January 31, 2025
NLS Pharmaceutics stock is trading higher on Friday after the company announced its merger with Kadimastem has been approved by Kadimastem shareholders.
Via
Benzinga
Which stocks are gapping on Friday?
January 31, 2025
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
January 31, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
January 31, 2025
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
What's going on in today's after hours session
January 30, 2025
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
What's Going On With NLS Pharmaceuticals Stock Monday?
December 30, 2024
NLS Pharmaceuticals stock is moving higher on Monday after the company announced it filed a F-4 registration statement with the SEC ahead of a proposed merger.
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment
December 19, 2024
Via
ACCESSWIRE
NLS Pharmaceutics CEO Issues Letter to Shareholders
December 11, 2024
Via
ACCESSWIRE
NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
December 03, 2024
Via
ACCESSWIRE
NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
November 18, 2024
Via
ACCESSWIRE
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
November 04, 2024
Via
Benzinga
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
Via
ACCESSWIRE
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
October 15, 2024
Via
ACCESSWIRE
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
September 26, 2024
Via
Benzinga
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
September 25, 2024
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 30, 2024
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Via
InvestorPlace
Dow Edges Lower; Ventyx Biosciences Shares Plummet
July 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 29, 2024
Via
Benzinga
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
July 29, 2024
Via
Benzinga
Exposures
Fossil Fuels
Tivic Health Systems (TIVC) Stock Pops Another 39%
July 29, 2024
Tivic Health Systems stock is up on Monday with heavy trading of TIVC shares as recent volatility continues for the company's units.
Via
InvestorPlace
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?
July 29, 2024
NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.
Via
InvestorPlace
NLS Pharmaceutics Announces Registered Direct Offering
June 28, 2024
Via
ACCESSWIRE
NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
June 27, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.